Celgene reports second quarter total revenue of $1.

On a GAAP basis, offering, general and administrative expenses had been $306 million for the next one fourth of 2011 and $219 million for the same period in 2010 2010. Interest and Other Income, Net Non-GAAP curiosity and other income, net, was a net expense of $5 million for the second quarter of 2011, weighed against a net good thing about $5 million for the second quarter of 2010, mainly because of interest expense associated with the $1.in October 2010 25 billion in senior notes issued. Cash, Money Equivalents, and Marketable Securities Cash, money equivalents, and marketable securities totaled $2.as of June 30 79 billion, 2011. Celgene repurchased 4.1 million shares during the second quarter for about $239 million..This latest high tech idea is an adaptation of PDT available to skin cancer patients already, where the affected region of skin is covered with a light – sensitive anti-malignancy cream, which is activated by controlled contact with a light source. Related StoriesStudy shows uncommon HER2 missense mutations usually do not spread breast cancer on their ownMD Anderson research reveals why chemotherapy drugs not effective for many pancreatic cancer patientsMeat-rich diet may increase kidney tumor riskThis involves large, cumbersome and intense light sources in hospital, involving the patient having to sit still for many hours. Professionals, Professor Ifor Samuel from St Andrews University and Professor James Ferguson from Dundee’s Ninewells Hospital, desire to market their brand-new invention and state it really is a low-cost, practical and portable method of treatment.